Dietary ModificationNCT03565510
The Impact of a High-protein Diet on Energy Metabolism in Healthy Men
A study testing High-Protein Diet in people with Dietary Modification, run by University of Alberta at 1 site in Canada.
Trial summary
The aim of this study is to investigate the impact of a high-protein diet (achieved with the use of a nutritional supplement, Almased®) versus a diet of a typical North American macronutrient distribution on energy metabolism, metabolic blood markers and appetite sensations. Read more about this study
- Who is it for?
- Ages 18 to 35 years, men onlyHealthy volunteers can take part
- Conditions the study is for
- Dietary Modification
- What is being tested?
- High-Protein Diet
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 27 participants
- Where
- 1 siteCanada
- Study dates
- 1 Aug 2018to 31 Oct 2019
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 35 years
- Men only
- Healthy volunteers accepted
- Adult
Who may be able to join
- Healthy;
- Non-smoker;
- Male;
- Aged 18 to 34.9 years;
- BMI between 18.5 and 24.9 kg/m² (preferably between 20 and 24.9 kg/m2);
Who cannot join
- Have previously been diagnosed with any chronic disease;
- Are taking any medications which may alter energy metabolism or body composition (exception: if taking antidepressants in a stable dose for > two months);
- Are lactose, gluten and/or soy allergic/intolerant;
- Follow a vegetarian, vegan or restrictive dietary pattern;
- Have used nutritional supplements in the past two months (except micronutrients);
- Are performing or have performed over an hour per day of leisure time physical activity or more than seven hours per week of strenuous activity in the past three months;
Show all 9Show fewer
- Have had a nuclear medicine scan or injection of an X-ray dye in the past week;
- Have had a barium test/exam in the last two weeks;
- Suffer from claustrophobia.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: A Randomized, Controlled, Cross-over Trial Investigating the Impact of a High-protein Diet on Energy Metabolism in Healthy Men
The aim of this study is to investigate the impact of a high-protein diet (achieved with the use of a nutritional supplement, Almased®) versus a diet of a typical North American macronutrient distribution on energy metabolism, metabolic blood markers and appetite sensations.
This study will be a randomized, controlled, cross-over trial of an acute nutritional intervention. A total of 20 participants will be randomly assigned (1:1) to one of the following groups:
Read more
- Control group (CON).
- High protein diet group (HP).
The diets given to participants in both groups will be eucaloric.
While receiving the diets in the whole body calorimetry unit for 32 hours, participants' overall changes in energy metabolism, metabolic blood markers, and appetite sensations will be assessed.
Read the detailed description
This study will be a randomized, controlled, cross-over trial of an acute nutritional intervention. The participants will be randomly assigned (1:1) to one of the following groups:
- Control group (CON). Those assigned to the CON will receive a diet composed of 55% of carbohydrate, 15% of protein, and 30% of lipid (similar to the North American dietary pattern [3]).
- High protein diet group (HP). Those assigned to the HP will receive a diet composed of 35% of carbohydrate, 40% of protein, and 25% of lipid constructed around a soy protein-based meal replacement (Almased®).
The diets given to participants in both groups will be eucaloric.
The following metabolic changes will be assessed between the diets:
- Energy metabolism (energy expenditure and substrate oxidation);
- Metabolic blood markers [glucose, insulin, lipid panel, peptide tyrosine-tyrosine (PYY), glucagon-like peptide-1 (GLP-1), ghrelin, leptin, free glycerol, and free fatty acids];
- Appetite sensations (hunger, satiety, fullness, and prospective food consumption).
Sample Size: A total of 18 participants will be able to detect an effect size of 1.41. The effect size was calculated based on changes in RQ (0.90 ± 0.04 in control group and 0.85 ± 0.03 in a high protein group) from a previously published study. Accounting for a 20% attrition rate (formula N=18/1-20%), the total sample size of 23 participants will have a power of 80% with a significance level of 5%. The sample size calculation was done using G*Power version 3.1.9.2.
Visit # 1 - Screening Visit: During the screening visit, the study coordinator will run through the study protocol and obtain written informed consent as well as participants' contact information. Eligibility to participate in the study will be based on set inclusion and exclusion criteria, completion of physical activity questionnaires, anthropometric assessment, bioelectrical impedance analysis (BIA), and analysis of biomarkers for kidney and liver function, electrolyte status, and thyroid-stimulating hormone.
Visit # 2 - Orientation Visit: During the orientation visit, participants will answer questions related to their health status and food preferences, will have their energy requirements assessed by an 1-hour WBCU test and will be provided an explanation about the run-in diet period. Body composition will also be assessed using dual energy X-ray absorptiometry (DXA) and air displacement plethysmography (ADP).
Visits # 3 \& 5 - Fitness Test \& Run-In Diet Visit: To standardize the exercise intensity while in the WBCU, participants will attend a fitness test visit prior to their first WBCU test visit. They will perform a submaximal exercise test on a treadmill (Freemotion Incline Trainer). The exercise test will begin at an individualized walking speed characterized as comfortable and sustainable. The incline will increase by 2% every three minutes until a RER of 0.9 has been achieved. During exercise, expired gases will be analyzed by a calibrated TrueMax® metabolic measurement system (ParvoMedics, Sandy, UT). To reproduce the same conditions during the WBCU exercise session, a breakfast identical to that provided inside the WBCU (CON Group) will be given to participants at 9 am and the treadmill test will start at 10:20 am. To determine the workload for the WBCU exercise session, each participant's respiratory exchange ratio (RER) will be plotted against their fitness test workload. The workload at which an RER of 0.85 occurred will be selected as the workload for the WBCU. We anticipate there will be a RER of 0.85 ± 0.03 during the WBCU control exercise session. The small difference may be due to factors such as the change in substrate oxidation throughout a 40-minute bout of exercise.
After the fitness test, participants will receive all the meals necessary to complete the 3-day run-in diet. This will standardize dietary intake among participants and minimize the effects of any eating style/behaviours on baseline data. The run-in diet will be a eucaloric diet and will have the same macronutrient distribution as of CON group diet (55% of carbohydrate, 15% of protein, and 30% of lipid). During this three-day run-in diet period, participants will be asked to abstain from any strenuous exercise, including endurance and/or resistance exercises. They can exercise (moderate) and drink coffee during the first and second days of run-in diet, but not during the third day.
Visits # 4 \& 6 - Whole Body Calorimetry Test Visits: Participants will complete a WBCU test visit twice during the study period, which will occur after the run-in diet periods. These visits will consist of two 32 hours (1.5 days) energy expenditure assessments inside the WBCU. During the 32-hour measurement period, participants of both groups (CON and HP) will be provided with a five-meal diet (breakfast, lunch, dinner, and two snacks) through an air-lock drawer system. The CON group will receive a diet composed of 55% of carbohydrate, 15% of protein, and 30% of lipid. The participants will receive breakfast, lunch, dinner and two snacks (afternoon and evening). The HP group will receive a diet composed of 35% of carbohydrate, 40% of protein, and 25% of lipid constructed around a soy protein-based meal replacement (Almased®). Participants will consume approximately 1 gram of Almased® per kg of body weight mixed with olive oil and low-fat milk (1% fat) in their breakfast, lunch and dinner. Two snacks (afternoon and evening) composed of approximately 1 gram of Almased® per kg of body weight mixed with apple juice and olive oil will also be provided. Amounts of low-fat milk, olive oil, and apple juice will be adjusted on an individual basis in order to achieve the desired macronutrient composition for the HP group. A variation of ± 2% for each macronutrient and ± 50 kcal/day will be considered.
The exercise session will be performed on the first morning (from 10:20 a.m. to 11:00 a.m.) spent in the WBCU. The session will be performed on a treadmill (BH T10 Pro Treadmill). The speed and grade of the treadmill will be set based on the fitness test as previously described.
Blood samples will be taken four times while participants are in the WBCU:
- Fasting on the first day (at 07:45 a.m.);
- After the exercise session on the first day (at 11:00 a.m.);
- Two hours postprandial on the first day (at 02:30 p.m.);
- Fasting on the second day (at 08:30 a.m.). The following blood markers will be analysed: glucose, insulin, lipid panel, PYY, GLP-1, ghrelin, leptin, free glycerol, and free-fatty acid. While participants are inside the WBCU, urine must be collected during the entire time. This is necessary to determine total nitrogen excretion, protein used by participant's body during the test day. Participants will be asked to rate their appetite sensations on a 100-mm visual analogue scale (VAS) immediately before and 30 minutes after each meal and snack provided in the WBCU in order to measure subjective appetite sensations (hunger, satiety, fullness, and prospective food consumption). Participants will be asked to wear an accelerometer around the wrist during sleep. The motion sensor will measure participants' activity patterns during sleep. A two week wash-out period between the WBCU test visits is needed to reduce the carryover effects of the interventions. A two week washout period is typical of feeding trials with soy isoflavone intervention [4, 5].
Statistical Analyses: Data distributions will be evaluated by the Shapiro-Wilk W-test. Parametric variables will be expressed in average and standard deviation and then converted into delta scores (i.e. post-pre values). To determine the differences among the variables analyzed after the intervention (within) and between CON and HP groups (between), Student's t-test or Mann-Whitney tests will be applied, according to data distribution. Pearson's correlation coefficients will be determined to assess whether there is a statistically significant correlation among the variables. All analyses will be performed using SPSS version 22.0, considering a critical significance value of 5%.
- Conditions
- Dietary Modification
- Being tested
- High-Protein Diet
- Keywords
- High-protein diet, Energy metabolism
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
High-Protein DietDietary supplement
The high-protein diet is composed of 35% of carbohydrate, 40% of protein, and 25% of lipid constructed around a soy protein-based meal replacement.
| Study group | Role | What they receive |
|---|---|---|
| Control | No intervention | Those assigned to the Control group will receive a diet composed of 55% of carbohydrate, 15% of protein, and 30% of lipid (similar to the North American dietary pattern). |
| High-Protein Diet | Experimental | Those assigned to the High-Protein Diet group will receive a diet composed of 35% of carbohydrate, 40% of protein, and 25% of lipid constructed around a soy protein-based total diet replacement. Receives: Dietary Supplement: High-Protein Diet |
What is being measured
The primary outcome is the main question the study is designed to answer.
Difference in fat balance assessed by indirect calorimetry during 32 hours of a high-protein (HP) total diet replacement compared to 32hours of a control (CON) diet.
To measure the differences in fat balance during 32 hours of a high-protein (HP) total diet replacement compared to 32hours of a control (CON) diet.
Measured: During a 32-hour period while receiving a HP total diet replacement or a CON diet.
Secondary outcomes (1)
Difference in 24-hour energy expenditure assessed by indirect calorimetry during 32 hours of a high-protein (HP) total diet replacement compared to 32hours of a control (CON) diet.
To measure the differences in 24-hour energy expenditure during 32 hours of a high-protein (HP) total diet replacement compared to 32 hours of a control (CON) diet.
Measured: During a 32-hour period while receiving a HP total diet replacement or a CON diet.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted21 Jun 2018
- Study start1 Aug 2018
- Primary completion31 Oct 2019
- Study completion31 Oct 2019
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (3)Papers the sponsor has linked to this study.
- Other trials for Dietary ModificationStudies of the same condition, open and under way.
- More trials run by University of AlbertaThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Basic science
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- None (open label)
- Enrolment
- 27 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Alberta
- Sponsor type
- University, hospital or other
- Collaborators
- Almased Wellness GmbH
- Responsible party
- Principal investigator, Carla Prado, University of Alberta
- Investigators
- Carla Prado, PhD, Principal investigator, University of Alberta
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03565510
- Sponsor's protocol ID
- Pro00083005
- Status last verified
- Jan 2020
- First submitted
- 11 Jun 2018
- Last updated
- 23 Jan 2020
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Oliveira CLP, Boule NG, Elliott SA, Sharma AM, Siervo M, Berg A, Ghosh S, Prado CM. A high-protein total diet replacement alters the regulation of food intake and energy homeostasis in healthy, normal-weight adults. Eur J Nutr. 2022 Jun;61(4):1849-1861. doi: 10.1007/s00394-021-02747-1. Epub 2021 Dec 20.
PubMed 34928408Oliveira CLP, Boule NG, Sharma AM, Elliott SA, Siervo M, Ghosh S, Berg A, Prado CM. A high-protein total diet replacement increases energy expenditure and leads to negative fat balance in healthy, normal-weight adults. Am J Clin Nutr. 2021 Feb 2;113(2):476-487. doi: 10.1093/ajcn/nqaa283.
PubMed 33247306Oliveira CLP, Boule NG, Sharma AM, Elliott S, Siervo M, Ghosh S, Berg A, Prado CM. Examining the effects of a high-protein total diet replacement on energy metabolism, metabolic blood markers, and appetite sensations in healthy adults: protocol for two complementary, randomized, controlled, crossover trials. Trials. 2019 Dec 27;20(1):787. doi: 10.1186/s13063-019-3950-y.
PubMed 31881910
Study at a glance
From the registry record, last updated by the sponsor on 23 Jan 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Randomized, Controlled, Cross-over Trial Investigating the Impact of a High-protein Diet on Energy Metabolism in Healthy Men
- ClinicalTrials.gov ID
- NCT03565510
- Acronym / sponsor ID
- Pro00083005
- Conditions
- Dietary Modification
- Keywords
- High-protein diet, Energy metabolism
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 27 participants (actual)
- Lead sponsor
- University of AlbertaUniversity, hospital or other
- Collaborators
- Almased Wellness GmbH
- Study start
- 1 Aug 2018 (actual)
- Primary completion
- 31 Oct 2019 (actual)
- Study completion
- 31 Oct 2019 (actual)
- First posted
- 21 Jun 2018 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of this study is to investigate the impact of a high-protein diet (achieved with the use of a nutritional supplement, Almased®) versus a diet of a typical North American macronutrient distribution on energy metabolism, metabolic blood markers and appetite sensations.
This study will be a randomized, controlled, cross-over trial of an acute nutritional intervention. A total of 20 participants will be randomly assigned (1:1) to one of the following groups:
- Control group (CON).
- High protein diet group (HP).
The diets given to participants in both groups will be eucaloric.
While receiving the diets in the whole body calorimetry unit for 32 hours, participants' overall changes in energy metabolism, metabolic blood markers, and appetite sensations will be assessed.
Detailed description
This study will be a randomized, controlled, cross-over trial of an acute nutritional intervention. The participants will be randomly assigned (1:1) to one of the following groups:
- Control group (CON). Those assigned to the CON will receive a diet composed of 55% of carbohydrate, 15% of protein, and 30% of lipid (similar to the North American dietary pattern [3]).
- High protein diet group (HP). Those assigned to the HP will receive a diet composed of 35% of carbohydrate, 40% of protein, and 25% of lipid constructed around a soy protein-based meal replacement (Almased®).
The diets given to participants in both groups will be eucaloric.
The following metabolic changes will be assessed between the diets:
- Energy metabolism (energy expenditure and substrate oxidation);
- Metabolic blood markers [glucose, insulin, lipid panel, peptide tyrosine-tyrosine (PYY), glucagon-like peptide-1 (GLP-1), ghrelin, leptin, free glycerol, and free fatty acids];
- Appetite sensations (hunger, satiety, fullness, and prospective food consumption).
Sample Size: A total of 18 participants will be able to detect an effect size of 1.41. The effect size was calculated based on changes in RQ (0.90 ± 0.04 in control group and 0.85 ± 0.03 in a high protein group) from a previously published study. Accounting for a 20% attrition rate (formula N=18/1-20%), the total sample size of 23 participants will have a power of 80% with a significance level of 5%. The sample size calculation was done using G*Power version 3.1.9.2.
Visit # 1 - Screening Visit: During the screening visit, the study coordinator will run through the study protocol and obtain written informed consent as well as participants' contact information. Eligibility to participate in the study will be based on set inclusion and exclusion criteria, completion of physical activity questionnaires, anthropometric assessment, bioelectrical impedance analysis (BIA), and analysis of biomarkers for kidney and liver function, electrolyte status, and thyroid-stimulating hormone.
Visit # 2 - Orientation Visit: During the orientation visit, participants will answer questions related to their health status and food preferences, will have their energy requirements assessed by an 1-hour WBCU test and will be provided an explanation about the run-in diet period. Body composition will also be assessed using dual energy X-ray absorptiometry (DXA) and air displacement plethysmography (ADP).
Visits # 3 \& 5 - Fitness Test \& Run-In Diet Visit: To standardize the exercise intensity while in the WBCU, participants will attend a fitness test visit prior to their first WBCU test visit. They will perform a submaximal exercise test on a treadmill (Freemotion Incline Trainer). The exercise test will begin at an individualized walking speed characterized as comfortable and sustainable. The incline will increase by 2% every three minutes until a RER of 0.9 has been achieved. During exercise, expired gases will be analyzed by a calibrated TrueMax® metabolic measurement system (ParvoMedics, Sandy, UT). To reproduce the same conditions during the WBCU exercise session, a breakfast identical to that provided inside the WBCU (CON Group) will be given to participants at 9 am and the treadmill test will start at 10:20 am. To determine the workload for the WBCU exercise session, each participant's respiratory exchange ratio (RER) will be plotted against their fitness test workload. The workload at which an RER of 0.85 occurred will be selected as the workload for the WBCU. We anticipate there will be a RER of 0.85 ± 0.03 during the WBCU control exercise session. The small difference may be due to factors such as the change in substrate oxidation throughout a 40-minute bout of exercise.
After the fitness test, participants will receive all the meals necessary to complete the 3-day run-in diet. This will standardize dietary intake among participants and minimize the effects of any eating style/behaviours on baseline data. The run-in diet will be a eucaloric diet and will have the same macronutrient distribution as of CON group diet (55% of carbohydrate, 15% of protein, and 30% of lipid). During this three-day run-in diet period, participants will be asked to abstain from any strenuous exercise, including endurance and/or resistance exercises. They can exercise (moderate) and drink coffee during the first and second days of run-in diet, but not during the third day.
Visits # 4 \& 6 - Whole Body Calorimetry Test Visits: Participants will complete a WBCU test visit twice during the study period, which will occur after the run-in diet periods. These visits will consist of two 32 hours (1.5 days) energy expenditure assessments inside the WBCU. During the 32-hour measurement period, participants of both groups (CON and HP) will be provided with a five-meal diet (breakfast, lunch, dinner, and two snacks) through an air-lock drawer system. The CON group will receive a diet composed of 55% of carbohydrate, 15% of protein, and 30% of lipid. The participants will receive breakfast, lunch, dinner and two snacks (afternoon and evening). The HP group will receive a diet composed of 35% of carbohydrate, 40% of protein, and 25% of lipid constructed around a soy protein-based meal replacement (Almased®). Participants will consume approximately 1 gram of Almased® per kg of body weight mixed with olive oil and low-fat milk (1% fat) in their breakfast, lunch and dinner. Two snacks (afternoon and evening) composed of approximately 1 gram of Almased® per kg of body weight mixed with apple juice and olive oil will also be provided. Amounts of low-fat milk, olive oil, and apple juice will be adjusted on an individual basis in order to achieve the desired macronutrient composition for the HP group. A variation of ± 2% for each macronutrient and ± 50 kcal/day will be considered.
The exercise session will be performed on the first morning (from 10:20 a.m. to 11:00 a.m.) spent in the WBCU. The session will be performed on a treadmill (BH T10 Pro Treadmill). The speed and grade of the treadmill will be set based on the fitness test as previously described.
Blood samples will be taken four times while participants are in the WBCU:
- Fasting on the first day (at 07:45 a.m.);
- After the exercise session on the first day (at 11:00 a.m.);
- Two hours postprandial on the first day (at 02:30 p.m.);
- Fasting on the second day (at 08:30 a.m.). The following blood markers will be analysed: glucose, insulin, lipid panel, PYY, GLP-1, ghrelin, leptin, free glycerol, and free-fatty acid. While participants are inside the WBCU, urine must be collected during the entire time. This is necessary to determine total nitrogen excretion, protein used by participant's body during the test day. Participants will be asked to rate their appetite sensations on a 100-mm visual analogue scale (VAS) immediately before and 30 minutes after each meal and snack provided in the WBCU in order to measure subjective appetite sensations (hunger, satiety, fullness, and prospective food consumption). Participants will be asked to wear an accelerometer around the wrist during sleep. The motion sensor will measure participants' activity patterns during sleep. A two week wash-out period between the WBCU test visits is needed to reduce the carryover effects of the interventions. A two week washout period is typical of feeding trials with soy isoflavone intervention [4, 5].
Statistical Analyses: Data distributions will be evaluated by the Shapiro-Wilk W-test. Parametric variables will be expressed in average and standard deviation and then converted into delta scores (i.e. post-pre values). To determine the differences among the variables analyzed after the intervention (within) and between CON and HP groups (between), Student's t-test or Mann-Whitney tests will be applied, according to data distribution. Pearson's correlation coefficients will be determined to assess whether there is a statistically significant correlation among the variables. All analyses will be performed using SPSS version 22.0, considering a critical significance value of 5%.
Study design
- Primary purpose
- Basic science
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Control | No intervention | –Those assigned to the Control group will receive a diet composed of 55% of carbohydrate, 15% of protein, and 30% of lipid (similar to the North American dietary pattern). |
| High-Protein Diet | Experimental | Dietary Supplement: High-Protein DietThose assigned to the High-Protein Diet group will receive a diet composed of 35% of carbohydrate, 40% of protein, and 25% of lipid constructed around a soy protein-based total diet replacement. |
Who may qualify
- Ages
- 18 to 35 years
- Sex
- Male only
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (5 listed)
- Healthy;
- Non-smoker;
- Male;
- Aged 18 to 34.9 years;
- BMI between 18.5 and 24.9 kg/m² (preferably between 20 and 24.9 kg/m2);
Key exclusion criteria (9 listed)
- Have previously been diagnosed with any chronic disease;
- Are taking any medications which may alter energy metabolism or body composition (exception: if taking antidepressants in a stable dose for > two months);
- Are lactose, gluten and/or soy allergic/intolerant;
- Follow a vegetarian, vegan or restrictive dietary pattern;
- Have used nutritional supplements in the past two months (except micronutrients);
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| High-Protein DietThe high-protein diet is composed of 35% of carbohydrate, 40% of protein, and 25% of lipid constructed around a soy protein-based meal replacement. | Dietary supplement | High-Protein Diet |
Primary outcome
Difference in fat balance assessed by indirect calorimetry during 32 hours of a high-protein (HP) total diet replacement compared to 32hours of a control (CON) diet.
Time frame: During a 32-hour period while receiving a HP total diet replacement or a CON diet.
To measure the differences in fat balance during 32 hours of a high-protein (HP) total diet replacement compared to 32hours of a control (CON) diet.
1 secondary outcome
Difference in 24-hour energy expenditure assessed by indirect calorimetry during 32 hours of a high-protein (HP) total diet replacement compared to 32hours of a control (CON) diet.
Time frame: During a 32-hour period while receiving a HP total diet replacement or a CON diet.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 23 Jan 2020.
- Derived from this study: PubMed 34928408Oliveira CLP, Boule NG, Elliott SA, Sharma AM, Siervo M, Berg A, Ghosh S, Prado CM. A high-protein total diet replacement alters the regulation of food intake and energy homeostasis in healthy, normal-weight adults. Eur J Nutr. 2022 Jun;61(4):1849-1861. doi: 10.1007/s00394-021-02747-1. Epub 2021 Dec 20.
- Derived from this study: PubMed 33247306Oliveira CLP, Boule NG, Sharma AM, Elliott SA, Siervo M, Ghosh S, Berg A, Prado CM. A high-protein total diet replacement increases energy expenditure and leads to negative fat balance in healthy, normal-weight adults. Am J Clin Nutr. 2021 Feb 2;113(2):476-487. doi: 10.1093/ajcn/nqaa283.
- Derived from this study: PubMed 31881910Oliveira CLP, Boule NG, Sharma AM, Elliott S, Siervo M, Ghosh S, Berg A, Prado CM. Examining the effects of a high-protein total diet replacement on energy metabolism, metabolic blood markers, and appetite sensations in healthy adults: protocol for two complementary, randomized, controlled, crossover trials. Trials. 2019 Dec 27;20(1):787. doi: 10.1186/s13063-019-3950-y.
- Individual participant dataSharing planned: No
Related trials for Dietary Modification
Active, not recruiting
A Pilot Factorial Trial of an Integrated Lifestyle Intervention
Physical Inactivity, Overweight and Obesity
Not yet recruiting
Testing a Smartphone App to Support a Mediterranean Diet and Strength Exercise
Treatment Adherence and Compliance, Resistance Exercise
Recruiting
An Online Intuitive Eating Program for Pregnant Women With Obesity to Support Well-Being
Excessive Gestational Weight Gain, Pregnancy
Recruiting
Dietary Intervention Study on Liver Health in Young Adults
Liver Health
Active, not recruiting
Effects of an Anti-Inflammatory Diet on Inflammatory and Neuroendocrine Responses After Lumbar Discectomy
Lumbar Discectomy
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Carla Prado, PhD principal investigator
University of Alberta
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing High-Protein Diet in people with Dietary Modification, run by University of Alberta at 1 site in Canada.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 23 Jan 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Difference in fat balance assessed by indirect calorimetry during 32 hours of a high-protein (HP) total diet replacement compared to 32hours of a control (CON) diet. (time frame: During a 32-hour period while receiving a HP total diet replacement or a CON diet.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03565510, which also lists 3 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jan 2020.